Today: 14 May 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Cabaletta Bio Stock Jumps: Inside the $150 Million Bet on CABA’s Cell Therapy

Cabaletta Bio Stock Jumps: Inside the $150 Million Bet on CABA’s Cell Therapy

Cabaletta Bio shares surged 32% after the company reported early results from its cell-therapy trial and priced a $150 million stock offering with participation from Eli Lilly and others. Two of four pemphigus vulgaris patients showed clinical activity with rese-cel, its experimental CAR-T therapy. The company expects to fund operations into mid-2027. New data will be presented at the ASGCT meeting on May 14.
Union Pacific’s $85 Billion Norfolk Southern Merger Faces a New Walk-Away Test

Union Pacific’s $85 Billion Norfolk Southern Merger Faces a New Walk-Away Test

Union Pacific warned it could drop its $85 billion bid for Norfolk Southern if U.S. regulators require major line sales or trackage rights as merger conditions. The Surface Transportation Board is still reviewing whether the revised application is complete, with a May 8 deadline for comments. CSX and other rivals have stepped up opposition, citing reduced competition. Union Pacific may owe Norfolk Southern a $2.5 billion fee if it walks away.
Mirum Stock Jumps After Volixibat Trial Win Puts First PSC Itch Drug Within Reach

Mirum Stock Jumps After Volixibat Trial Win Puts First PSC Itch Drug Within Reach

Mirum Pharmaceuticals said its drug volixibat met the main goal in a 158-patient Phase 2b trial for primary sclerosing cholangitis, reducing itch scores more than placebo. Shares rose about 9% after the announcement. The company plans a pre-NDA meeting with the FDA this summer and aims to file for U.S. approval in the second half of 2026. No FDA-approved therapies currently exist for this rare liver disease.
Sangamo Stock Jumps Before Nasdaq Exit: Why SGMO Investors Are Watching May 5

Sangamo Stock Jumps Before Nasdaq Exit: Why SGMO Investors Are Watching May 5

Sangamo Therapeutics shares jumped about 33% Monday as the company prepared to move from Nasdaq to the OTCQB Venture Market following a delisting notice over its sub-$1 share price. Nasdaq is set to suspend trading in SGMO on May 5. Sangamo said it will appeal but expects trading to shift regardless. The company is seeking new funding and continues talks on partnerships and its Fabry disease gene therapy.
4 May 2026
Above Food Ingredients (ABVE) Stock Jumps as Delayed 20-F Filing Keeps Investors on Edge

Above Food Ingredients (ABVE) Stock Jumps as Delayed 20-F Filing Keeps Investors on Edge

Above Food Ingredients shares surged about 22% to $0.65 in heavy Nasdaq trading Monday, with volume topping 42 million shares. The rally came as the company’s fiscal 2025 annual report remained delayed due to an ongoing audit. Above Food last reported a net loss of $53.3 million and a working-capital deficit of $85.4 million. Peer food and ingredient stocks moved little by comparison.
Cenovus Energy Stock Climbs Before Q1 Results as CIBC Puts MEG Deal in Focus

Cenovus Energy Stock Climbs Before Q1 Results as CIBC Puts MEG Deal in Focus

Cenovus Energy shares climbed 2.9% to C$40.96 in Toronto after CIBC Capital Markets reaffirmed an outperformer rating and set a C$46 target ahead of first-quarter results. CIBC estimated quarterly production at 962,000 barrels of oil equivalent per day and projected cash flow per share of C$1.63, above consensus. Cenovus will report results May 6, its first full quarter including former MEG Energy assets.
Celcuity Stock Jumps 16% as Gedatolisib Breast-Cancer Data Raise FDA Stakes

Celcuity Stock Jumps 16% as Gedatolisib Breast-Cancer Data Raise FDA Stakes

Celcuity Inc. shares rose nearly 16% Monday after reporting its breast cancer drug gedatolisib met the main goal in a late-stage trial for patients with PIK3CA-mutant tumors. The company plans to submit the new data to the FDA as a supplemental application. Celcuity traded at $145.54, up $19.89, with a market value near $6.9 billion. A July 17 FDA decision on gedatolisib for a related use remains pending.
DoorDash Just Opened Kroger Delivery to SNAP Cards at 2,700 Stores

DoorDash Just Opened Kroger Delivery to SNAP Cards at 2,700 Stores

National Grid’s London shares did not trade Monday due to the UK bank holiday, while its New York ADR fell $1.12 to $87.36. Investors await May 14 full-year results after the company warned of a roughly 1 pence EPS hit from U.S. regulatory refunds and storm costs. U.S. peers Eversource and Avangrid are seeking higher allowed returns from FERC following a March ruling that cut rates and ordered $1.5 billion in refunds.
Mobile-health Network Solutions Stock Jumps After $119 Million AI Health Deal: What MNDR Investors Need To Know

Mobile-health Network Solutions Stock Jumps After $119 Million AI Health Deal: What MNDR Investors Need To Know

Mobile-health Network Solutions signed a non-binding US$119 million framework with Hector Capital to fund planned acquisitions of BIMA and M&M Helix. The deal follows MNDR’s separate US$126 million data-center financing plan. MNDR shares jumped about 60% to $1.52 after the news. The agreement requires further valuation, approvals, and definitive contracts.
SEALSQ Stock Alert: Quantum-Security Name Draws Heavy Call Buying Before Key Shareholder Vote

SEALSQ Stock Alert: Quantum-Security Name Draws Heavy Call Buying Before Key Shareholder Vote

SEALSQ Corp shares climbed about 5% to $3.015 on Nasdaq Monday, with trading volume topping 12.9 million and call-option activity up 227% from average. The move comes ahead of the company’s May 7 shareholder meeting in Miami. SEALSQ reported preliminary Q1 revenue of $4.1 million, more than triple last year’s figure, and reaffirmed 2026 growth guidance. First revenue from post-quantum products is expected in late 2026.
Sivers Semiconductors Stock Jumps 47% as Nasdaq Push and AI Optics Bet Hit Deadline Week

Sivers Semiconductors Stock Jumps 47% as Nasdaq Push and AI Optics Bet Hit Deadline Week

Sivers Semiconductors shares jumped 47.24% to SEK 55.95 in Stockholm, extending 2024 gains to over 1,200%. Shareholders face a May 5 deadline to participate in a SEK 125 million directed share issue ahead of a May 11 vote. The company delayed its 2025 annual report to May 15 to meet U.S. audit standards for a possible Nasdaq New York dual listing. Market value stood at SEK 16.59 billion.
Destiny Tech100 Stock Surges Again As DXYZ’s SpaceX And AI Bet Draws Fresh Traders

Destiny Tech100 Stock Surges Again As DXYZ’s SpaceX And AI Bet Draws Fresh Traders

Norwegian Cruise Line Holdings cut its 2026 adjusted earnings forecast to $1.45–$1.79 per share, citing higher fuel costs and weaker bookings linked to Middle East unrest. First-quarter revenue rose 10% to $2.3 billion, but missed analyst estimates. Shares fell 9% to $17.08. CEO John Chidsey said the company is taking cost-cutting measures and faces a tougher outlook than competitors.
Blaize Stock Jumps as $15 Million Winmate AI Deal Targets Defense Hardware

Blaize Stock Jumps as $15 Million Winmate AI Deal Targets Defense Hardware

Blaize Holdings shares jumped 33.5% to $2.71 after announcing a partnership with Taiwan’s Winmate Inc. to integrate Blaize AI chips into rugged field systems. The companies target about $15 million in business in the first year, though this reflects a sales goal, not confirmed revenue. Trading volume exceeded 34 million shares. Blaize reports first-quarter results May 14.
1 33 34 35 36 37 811

Stock Market Today

  • STERIS (STE) Valuation Review Amid Recent Share Price Decline
    May 14, 2026, 2:08 PM EDT. STERIS (STE) share price fell about 6% in the past month and nearly 14% over three months, attracting investor scrutiny. The company, with a market value of $20.68 billion, operates mainly in Healthcare and Life Sciences, generating $5.94 billion revenue and $782 million net income annually. Despite recent weakness, it offers a 16.78% total shareholder return over five years, signaling steadier long-term growth. Analysts' models suggest the stock is 24.4% undervalued, with a fair value near $279, buoyed by expectations of revenue and margin expansion in consumables and services. However, a 26.5x price-to-earnings ratio exceeds the industry average, highlighting risk if growth falters. Investors should weigh potential tariff and reimbursement challenges against premium pricing implied by current valuations.

Latest articles

PureCycle Stock Jumps 25% as New Jersey Approval Opens Door to Recycled Plastic Demand

PureCycle Stock Jumps 25% as New Jersey Approval Opens Door to Recycled Plastic Demand

14 May 2026
PureCycle Technologies shares rose 24.7% to $12.72 after New Jersey regulators granted its PureFive resin a one-year conditional designation as postconsumer recycled content under state packaging law. The company reported first-quarter revenue of $4.1 million and a net loss of $33.4 million. Production at its Ohio plant doubled from a year earlier. PureCycle plans to seek permanent approval from state regulators.
GTA 6 Preorder Rumor Sends Take-Two Stock Higher. The Bigger Test Comes Next Week

GTA 6 Preorder Rumor Sends Take-Two Stock Higher. The Bigger Test Comes Next Week

14 May 2026
Take-Two Interactive shares rose 6.5% to $241.68 on Thursday after reports of a leaked Best Buy affiliate campaign fueled speculation that Grand Theft Auto VI pre-orders could begin next week. Neither Take-Two nor Rockstar Games has confirmed a pre-order date. The company is set to report earnings after markets close on May 21. GTA VI is listed for release on Nov. 19, 2026, for PlayStation 5 and Xbox Series X|S.
Mobix Labs Stock Jumps After Rare-Earth Deal Puts Defense Supplier in China Supply-Chain Fight

Mobix Labs Stock Jumps After Rare-Earth Deal Puts Defense Supplier in China Supply-Chain Fight

14 May 2026
Mobix Labs shares jumped 86% Thursday after announcing a non-binding letter of intent to acquire Special Project Delivery LLC, a private U.S. rare earths and critical minerals platform. The move comes as U.S. rules tighten on defense sourcing and Chinese exports of heavy rare earths remain sharply restricted. No purchase price was disclosed, and Mobix said a deal is not assured. SPD specializes in extracting rare earths from U.S. coal ash.
Lumen Stock Surges After $2.4 Billion Debt Move Puts AI Fiber Turnaround in Focus

Lumen Stock Surges After $2.4 Billion Debt Move Puts AI Fiber Turnaround in Focus

14 May 2026
Lumen Technologies shares rose 14% Thursday, trading at $10.76 after hitting $11.27, as investors reacted to its debt refinancing and AI-focused network expansion. Level 3 Financing refinanced secured loans, leaving $2.4 billion outstanding under a repriced facility. Lumen also announced a new fiber route between Seattle and Minneapolis, set for completion by end-2026. First-quarter revenue fell to $2.899 billion, with a $200 million net loss.
Go toTop